Aurelia Foundry

Aurelia Foundry is a venture studio and biotechnology company dedicated to advancing the field of programmable biology. The company leverages a proprietary platform that integrates high-throughput CRISPR screening, synthetic biology, and machine learning to engineer cellular functions for therapeutic applications. Its primary focus is on developing next-generation cell therapies with enhanced precision, potency, and durability, particularly for oncology and immunology. By systematically exploring the genetic landscape of human cells, Aurelia Foundry aims to accelerate the discovery and development of novel medicines. The organization operates as both a developer of internal programs and a builder of specialized biotech entities like its first spin-out, Aurelia.